FDA Clearance Tracker · K233904
ACIST RXi System (016616); ACIST Navvus II Catheter (016675_
Last checked: Nov 20, 2026Latest source record: Jul 17, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jul 17, 2024
Substantially Equivalent
Time to decision
219 days
Received Dec 11, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K233904
- Device name
- ACIST RXi System (016616); ACIST Navvus II Catheter (016675_
- Applicant
- Acist Medical Systems, Inc.
- Applicant location
- Eden Prairie, MN
- Received
- Dec 11, 2023
- Decided
- Jul 17, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Transducer, Pressure, Catheter Tip (DXO)
- Device class
- Class II
- Regulation
- 21 CFR 870.2870
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DXO. The earliest in FDA's data is K790036, decided Mar 2, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233904
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Acist Medical Systems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VueJect® Ultrasound Enhancing Agent Delivery SystemThird-party review510(k)
K262115 · Decided Aug 3, 2026 · 41 days after receipt
Device type: Injector, Contrast Medium, Automatic (IZQ) · Cardiology
K252638 · Decided May 13, 2026 · 266 days after receipt
Device type: Injector And Syringe, Angiographic (DXT) · Cardiology
K252653 · Decided May 13, 2026 · 264 days after receipt
Device type: Injector And Syringe, Angiographic (DXT) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.